<?xml version="1.0" encoding="UTF-8"?>
<p>The US has a wide range of research fields for infectious disease preparedness ranging from basic research (i.e., the identification and mechanism of the viral pathogen) (62.0%) to animal–environmental ecology and the epidemiologic investigation and quarantine of infectious diseases (23.8%) and has invested from a mid- to long-term perspective (see 
 <xref ref-type="fig" rid="healthcare-08-00204-f003">Figure 3</xref>). Although the funding scale for coronavirus-related R&amp;D areas in the EU and Japan is smaller than that of the United States, the directions for the R&amp;D areas are considerably analogous to those in the US. These trends in coronavirus-related R&amp;D funding show that the directions for the R&amp;D investment are in accordance with the “One Health” concept of the WHO, which is a global strategy for all aspects of healthcare for the environment–animal–human paradigm [
 <xref rid="B33-healthcare-08-00204" ref-type="bibr">33</xref>].
</p>
